Congenital Heart Disease — Hypoplastic Left Heart Syndrome

Key Mechanisms

1. Embryologic Maldevelopment of Left Heart Structures

• Primary defect: Underdevelopment of the left ventricle secondary to abnormal endocardial cushion tissue proliferation and reduced leftward growth of the cardiac tube during weeks 4–7 of gestation
• Reduced blood flow through the left side of the heart during fetal development triggers apoptosis and failure of normal ventricular myocardial proliferation (reduced myocardial trabeculation)
• The mitral valve is dysplastic or atretic; the aortic valve is stenotic or atretic
• The ascending aorta and aortic arch are severely hypoplastic, often <5 mm in diameter
• Left atrium may be hypoplastic or normal but receives minimal blood flow
• Molecular factors implicated include altered TBX5, NKX2-5, and NOTCH1 signaling, though most cases are sporadic

2. Obligatory Right-to-Left Shunting and Systemic Perfusion Dependence

• The right ventricle must provide systemic (via aorta) AND pulmonary circulation simultaneously
• The right atrium receives both systemic venous return (via superior and inferior vena cava) and pulmonary venous return (via pulmonary veins)
• Survival depends absolutely on: (1) patent foramen ovale (PFO) allowing right-to-left atrial shunting to decompress the right atrium and prevent pulmonary edema; (2) patent ductus arteriosus (PDA) allowing right ventricular outflow to perfuse the descending aorta and systemic circulation
• Pulmonary vascular resistance (PVR) must remain elevated relative to systemic vascular resistance (SVR) to preferentially direct right ventricular output systemically through the PDA rather than into the low-resistance pulmonary circulation

3. Circulatory Dynamics and Metabolic Consequence

• Mixing physiology: All systemic venous return and pulmonary venous return mix in the right atrium, resulting in complete mixing of oxygenated and deoxygenated blood (analogous to a single-ventricle physiology)
• Cardiac output distribution: The right ventricle ejects a single combined output that must be partitioned between systemic and pulmonary beds
• Systemic oxygen saturation: Typically 75–85% (compared to normal 95–100%), as the right atrium receives a mixture of systemic venous return (SvO₂ ~70%) and pulmonary venous return (PvO₂ ~98%)
• Metabolic acidosis develops rapidly if systemic perfusion is inadequate relative to oxygen demand, causing tissue hypoxia and lactate accumulation

Major Causes and Risk Factors

1. Genetic and Chromosomal Abnormalities

• Turner syndrome (45,X): Present in 5–10% of HLHS cases; XO karyotype associated with abnormal cardiac development and bicuspid aortic valve
• Trisomy 13 and 18: Increased incidence of HLHS with these aneuploidies
• Familial clustering: Rare autosomal dominant inheritance reported; mutations in TBX5, NKX2-5, NOTCH1, and GATA4 implicated
• Maternal factors: Pregestational diabetes, maternal phenytoin exposure, maternal infection (particularly enterovirus and parvovirus B19 in first trimester)

2. Environmental and Maternal Risk Factors

• Maternal diabetes: Pregestational diabetes increases risk 2–3 fold
• Maternal medications: First-trimester phenytoin, warfarin, and retinoid exposure
• Maternal infections: First-trimester viral infections (rubella, coxsackievirus, parvovirus B19) associated with increased risk
• Advanced maternal age: Weakly associated; more pronounced for chromosomal abnormalities
• Idiopathic: ~90% of cases are sporadic with no identifiable genetic or environmental cause

Cardinal Symptoms and Findings

Neonatal Period (First Days to Weeks of Life)

• Severe cyanosis and hypoxemia: Oxygen saturation typically 75–85% that does not improve with supplemental oxygen alone (pathognomonic mixed physiology); profound cyanosis visible within hours to days after birth as the ductus arteriosus constricts
• Signs of shock and poor perfusion: Weak pulses, poor feeding, lethargy, delayed capillary refill (>3 seconds), mottled skin, metabolic acidosis; represents inadequate systemic perfusion relative to metabolic demands
• Respiratory distress: Tachypnea (respiratory rate >60 breaths/min), nasal flaring, grunting; due to metabolic acidosis and pulmonary edema from excessive pulmonary blood flow if PVR is too low
• Cardiogenic shock: Hypotension, oliguria, hepatomegaly (congestion), altered consciousness in severe cases

Physical Examination Findings

• Single loud S2: The aortic component is absent or inaudible because the ascending aorta is hypoplastic; only the pulmonic component is heard, creating a single S2 (in contrast to physiologic splitting in normal children)
• Systolic murmur: A soft systolic ejection murmur may be heard at the left upper sternal border from right ventricular outflow, but the absence of a murmur does not exclude the diagnosis
• Active precordium: Hyperkinetic precordium reflecting increased right ventricular stroke volume and force of contraction
• Hepatomegaly: Often pronounced, reflecting right ventricular dysfunction and systemic venous congestion
• Cyanosis with minimal response to oxygen: This "hypercyanotic state unresponsive to supplemental oxygen" is classic and distinguishes mixing lesions from simple obstructive lesions
• Poor lower extremity pulses: May be diminished or delayed compared to upper extremities, reflecting decreased aortic arch perfusion (though upper extremity pulses may also be weak if systemic perfusion is severely compromised)

Complete Diagnostic Approach

1. Clinical Suspicion and Risk Stratification

• Antenatal diagnosis: Advanced fetal echocardiography (typically after 18–20 weeks gestation) can visualize hypoplastic left ventricle, small ascending aorta, and reverse flow in the aortic arch; allows for planned delivery at tertiary center with surgical capability, improving outcomes
• Postnatal presentation: Cyanosis and shock developing in the immediate neonatal period (first 12–72 hours) when the ductus arteriosus constricts is highly suggestive

2. Electrocardiography (ECG)

• Right axis deviation: QRS axis typically shifted rightward (60° to 180°) due to right ventricular dominance
• Right ventricular hypertrophy: Tall R waves in V1–V2; deep S waves in V5–V6
• Nonspecific ST-T wave changes
• Clinical utility: ECG is nonspecific; primarily useful to exclude other diagnoses (e.g., myocarditis, arrhythmia)

3. Chest X-Ray

• Cardiomegaly: Enlarged cardiac silhouette with increased cardiothoracic ratio (>60%)
• Pulmonary vascular engorgement: Increased pulmonary blood flow if PVR is low, manifesting as prominent pulmonary vascularity and pulmonary edema ("shaggy heart" appearance)
• Alternatively: Decreased pulmonary vascularization if PVR is elevated or systemic perfusion is severely compromised
• Mediastinal abnormality: Narrow mediastinum reflecting hypoplastic aortic arch

4. Echocardiography (Gold Standard for Diagnosis)

• Two-dimensional (2D) imaging:
• Hypoplastic left ventricle: Severely reduced left ventricular end-diastolic dimension (typically <2 standard deviations below normal for age); echogenic, non-compliant myocardium with reduced contractility
• Mitral valve abnormalities: Mitral valve atresia (complete closure/absence) or severe stenosis; reduced or absent flow across the mitral valve on color Doppler
• Aortic valve abnormalities: Aortic valve atresia or severe stenosis; hypoplastic ascending aorta (diameter typically <5 mm)
• Left atrium: May be normal or small; receives pulmonary venous return but transmits minimal flow across the mitral valve
• Right ventricular hypertrophy: Enlarged, thick-walled right ventricle
• Patent foramen ovale (PFO): Visualized as right-to-left shunt on color Doppler; essential for survival

• Doppler imaging:
• Retrograde (right-to-left) flow in aortic arch: Flow in the ascending aorta is retrograde, originating from the ductus arteriosus and perfusing the coronary circulation and upper extremities in reverse (right-to-left through the PDA)
• Right-to-left shunt across PFO: Doppler confirms continuous right-to-left flow at the atrial septum
• Patent ductus arteriosus (PDA) flow: Left-to-right flow (from pulmonary artery into descending aorta), providing the primary source of systemic blood flow
• Pulmonary regurgitation and tricuspid regurgitation: Often present due to right ventricular dilation

• Spectral Doppler:
• Pulsed-wave Doppler across mitral valve shows minimal or absent antegrade flow
• Continuous-wave Doppler across aortic and pulmonary valves characterizes valve stenosis/atresia

5. Cardiac Catheterization

• Current role: Primarily therapeutic rather than diagnostic (see Treatment section); diagnostic echocardiography is usually sufficient for diagnosis
• Historical role: Confirmed diagnosis and assessed hemodynamics; rarely needed now
• Indications for catheterization: Planned intervention (balloon atrial septostomy, PDA stent placement)

6. Diagnostic Criteria

• Anatomic: Hypoplastic left ventricle with mitral and/or aortic valve atresia/stenosis, hypoplastic ascending aorta, and intact atrial septum (or small PFO only)
• Hemodynamic: Right-to-left shunt across PFO; patent ductus arteriosus providing systemic blood flow; mixed venous and pulmonary venous blood in right atrium
• Functional: Systemic oxygen saturation 75–85% unresponsive to supplemental oxygen; metabolic acidosis if perfusion is inadequate

7. Associated Findings

• Chromosomal testing: Karyotype or microarray (chromosomal microarray analysis, CMA) recommended due to association with Turner syndrome and other aneuploidies
• Extracardiac anomalies: Screen for associated anomalies (central nervous system malformations, renal anomalies, limb defects) as part of syndromic evaluation

Comprehensive Management by Stage and Indication

1. Immediate Stabilization and Medical Management (Prostaglandin E1 Dependency)

Prostaglandin E1 (PGE1) Administration

• Mechanism: PGE1 is a vasodilator and inhibitor of platelet aggregation; critically, it prevents closure of the ductus arteriosus, maintaining the essential right-to-left shunt and systemic perfusion
• Dosing: Initial dose 0.05–0.1 μg/kg/min IV; titrate to effect (typically 0.01–0.4 μg/kg/min)
• Efficacy: Reopens a closing or closed ductus arteriosus within minutes to hours
• Complications: Apnea (20–40% of infants), fever, flushing, systemic hypotension; apnea risk necessitates mechanical ventilation in most cases
• Clinical pearl: Do not delay initiating PGE1 in suspected HLHS; this is a life-saving bridge to definitive intervention

Mechanical Ventilation and Respiratory Management

• Goals: Maintain PaO₂ 40–50 mmHg (not higher) and PaCO₂ 35–45 mmHg to keep pulmonary vascular resistance elevated and preferentially direct right ventricular output systemically via the PDA
• Rationale for "mild hyperoxia avoidance": Excessive supplemental oxygen causes pulmonary vasodilation, increasing pulmonary blood flow at the expense of systemic perfusion, worsening metabolic acidosis and shock
• Gentle ventilation strategy: Avoid excessive positive pressure, which increases intrathoracic pressure and decreases systemic venous return and diastolic aortic pressure (perfusion pressure to coronary arteries)
• Avoid hypocapnia: Hyperventilation reduces PaCO₂, causing pulmonary vasodilation; avoid aggressive hyperventilation

Metabolic Support

• Fluid management: Restrict fluids to 80–100 mL/kg/day to avoid pulmonary edema; monitor strict input/output
• Inotropic support: Dobutamine (2–10 μg/kg/min) or milrinone (0.5–1 μg/kg/min) to improve right ventricular contractility and systemic perfusion
• Avoid excessive PEEP: Positive end-expiratory pressure >5 cm H₂O reduces cardiac preload and systemic perfusion; use cautiously
• Correction of metabolic acidosis: Address through improved perfusion and oxygenation; avoid sodium bicarbonate initially as it increases PaCO₂ and worsens pulmonary vasodilation

Balloon Atrial Septostomy (Rashkind Procedure)

• Indication: If the PFO is restrictive or there is inadequate right-to-left shunting despite maximal medical therapy; can be performed at bedside or in the catheterization laboratory
• Mechanism: Enlarges the ASD by balloon dilation, creating adequate mixing at the atrial level to improve systemic oxygen saturation and reduce right atrial pressure
• Timing: Ideally performed within the first 24–48 hours if needed; before the PDA closes
• Success criteria: Increases systemic SaO₂ by >5–10% and reduces right atrial pressure

2. Definitive Surgical Repair — Staged Approach

Stage 1: Norwood Procedure (Initial Palliation, Days to Weeks of Life)

• Surgical goals: Create a new systemic outflow tract from the hypoplastic left heart to replace the function of the aortic valve and ascending aorta; separate pulmonary and systemic circulations partially
• Surgical technique:
• Division of the main pulmonary artery
• Connection of the proximal pulmonary artery to the hypoplastic aorta and aortic arch (aorto-pulmonary anastomosis) to create a neoaorta for systemic outflow
• Closure of the PDA
• Blalock-Taussig shunt (modified, mBT): Creation of a systemic-to-pulmonary artery shunt from the **subclavian or innominate ar

Pre-operative emergencies (unrepaired neonate)

• Ductal closure: loss of the sole systemic outflow tract; sudden pallor, absent pulses, anuria, and a rapidly widening lactate/base deficit. A true emergency — restart or escalate PGE1 and prepare for ECMO.
• Intact or highly restrictive atrial septum: pulmonary venous blood cannot decompress, producing pulmonary venous hypertension and lymphangiectasia; the neonate is profoundly cyanotic at the moment of birth and does not respond to ventilation or PGE1. Delivery-room emergency requiring immediate balloon septostomy or septectomy; prenatal diagnosis exists largely to have this team in the room.
• Pulmonary overcirculation: as PVR falls, right ventricular output steals into the lungs. The tell is a paradoxically high saturation (>90%) accompanied by acidosis, poor perfusion, and a bounding pulse with wide pulse pressure — high sats here are a danger signal, not reassurance.
• Necrotizing enterocolitis / mesenteric ischemia: diastolic runoff through the duct or shunt lowers splanchnic perfusion pressure; feeding intolerance, bloody stools, pneumatosis intestinalis.

After stage 1 (Norwood)

• Shunt thrombosis or stenosis (modified Blalock–Taussig–Thomas or Sano): abrupt severe desaturation with disappearance of the continuous shunt murmur — emergency anticoagulation, catheterization, or ECMO.
• Coronary hypoperfusion and arrhythmia: low aortic diastolic pressure from runoff, presenting as ST change, ventricular arrhythmia, or arrest.
• Arch recoarctation and neoaortic regurgitation: rising afterload with ventricular dysfunction and falling saturations.
• Interstage attrition: the period between Norwood and Glenn carries the highest mortality of the pathway; home pulse-oximetry and weight-gain surveillance programs exist for this reason.

After Glenn/Fontan

• Pulmonary arteriovenous malformations post-Glenn from absent hepatic venous "factor" — progressive cyanosis.
• Failing Fontan physiology: chronically elevated central venous pressure drives protein-losing enteropathy (hypoalbuminemia, edema, elevated stool alpha-1 antitrypsin), plastic bronchitis, and Fontan-associated liver disease progressing to cirrhosis and hepatocellular carcinoma — the AHA/ACC 2018 adult congenital heart disease guideline endorses lifelong specialist surveillance.
• Atrial arrhythmias and thromboembolism: poorly tolerated because Fontan output is preload-dependent; treat new atrial flutter urgently.
• Neurodevelopmental impairment and infective endocarditis (AHA endorses prophylaxis for palliative shunts/conduits and cyanotic unrepaired disease).

• Cyanosis plus shock in the first days of life = ductal-dependent lesion until proven otherwise: the single best next step is a prostaglandin E1 infusion, started on clinical suspicion before the echocardiogram returns. Anticipate apnea and secure the airway.
• Oxygen is a drug, and here it is the wrong one: 100% FiO2 vasodilates the pulmonary bed, steals right ventricular output from the systemic circulation, and worsens acidosis. Target modest saturations (roughly 75–85%). The stem that says "saturation improved to 95% and the baby became mottled and acidotic" is describing pulmonary overcirculation, not improvement.
• Single loud S2 with a hyperdynamic precordium and no significant murmur — the absent aortic component reflects aortic atresia/hypoplasia. Absence of a murmur never excludes HLHS.
• Echo buzzword: retrograde flow in the transverse arch and ascending aorta — the coronaries and head vessels are perfused backwards from the duct.
• The association examiners test: Turner syndrome (45,X) — also think coarctation and bicuspid aortic valve. Maternal pregestational diabetes is the other favored stem detail.
• Screening: newborn pulse-oximetry screening for critical congenital heart disease (pre- and post-ductal, performed after the first day of life, per AAP/AHA-endorsed protocols) is the population-level catch; a failed screen mandates echocardiography, not repeat oxygen.
• Common distractors: (1) Do not give indomethacin or ibuprofen — that closes the duct and kills the patient; PDA closure is beneficial only in the preterm infant without a ductal-dependent lesion. (2) Do not pick d-transposition — that stem gives egg-on-a-string with a narrow mediastinum and a neonate who improves dramatically after septostomy. (3) Diuretics and high-dose oxygen for "heart failure" are traps.
• Sequence to memorize: Norwood/Sano in the neonatal period → bidirectional Glenn around 4–6 months once pulmonary vascular resistance falls → Fontan in the toddler/preschool years. Heart transplantation is the alternative and the endpoint for the failing single ventricle.